Methodist International Begins Affiliation with Al Amal Hospital in Amman, Jordan

Methodist International, the global subsidiary of The Methodist Hospital in Houston, Texas, United States of America, has entered into an affiliation agreement with Al Amal Hospital to provide services for the design, development and commissioning of a new acute care hospital in Amman, Jordan.

Al"...

Mumzworld.com supports Walk For Autism 2013

Organised by Child Early Intervention Medical Center, the event has seen great participation year on year and was attended this year by more than 5,000 people eager to show their support to families and children affected by autism.

Mona Ataya, CEO, www.mumzworld.com, said: "Autism is the fastest growing developmental disorder, affecting one in 85 children;...

Nuvo Research Announces European Launch of Pliaglis® by Galderma

Nuvo Research Inc. (TSX:NRI), a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and Galderma Pharma, S.A. (Galderma), today announced the European launch of Pliaglis (lidocaine and tetracaine) Cream 7%/7%. Nuvo has licensed worldwide marketing rights for Pliaglis to Galderma, a global pharmaceutical...

ExxonMobil Marks World Malaria Day with Renewed Commitment to Combatting Malaria

• Support to continue in 2013 with $10 million in grants for the fight against malaria
• ExxonMobil-supported programs have distributed 13.1 million bed nets, 1.7 million top-line malaria treatments and 942,000 rapid diagnostic tests over the past 13 years

On the eve"...

Boehringer Ingelheim announces results from one of its HCV Phase III trials: Investigational compound faldaprevir+ shows high viral cure and early treatment success in treatment-naïve patients with genotype-1 hepatitis C

• In the Phase III clinical trial STARTVerso™1, up to 80% of patients treated with faldaprevir+ and PegIFN/RBV achieved viral cure (SVR12)
• At both doses, 87 to 89% of patients met criteria to stop all treatment after 24 weeks and 86 to 89% of these patients went on to achieve SVR12
• Faldaprevir+ was well tolerated at both doses; at the...
  Continue Reading

DuBiotech on mission to foster closer partnership with US business

A delegation from DuBiotech, a free zone dedicated to facilitating and fostering the growth of the life sciences industry in the UAE, will attend this week’s BIO International Convention in Chicago, Illinois, to educate and inform American investors about Dubai’s thriving biotech"...

Summertime Rejuvenation with Velvet International

Cosmeceutical supplier Velvet International’s products are increasingly popular as staple items in households becoming a part of the consumers’ routine personal care regimen for their ability to protect, beautify, and rejuvenate the skin and face.

Quintiles Wins Best CRO Award at World Vaccine Congress 2013

Recognition speaks to Quintiles’ Contribution to Vaccines Drug Development

World Vaccine Congress & Expo Washington 2013

For the second consecutive year, Quintiles has been named Best Clinical Research Organization (CRO) in the"......